Versatile Functions of Somatostatin and Somatostatin Receptors in the Gastrointestinal System
- PMID:33796080
- PMCID: PMC8009181
- DOI: 10.3389/fendo.2021.652363
Versatile Functions of Somatostatin and Somatostatin Receptors in the Gastrointestinal System
Abstract
Somatostatin (SST) and somatostatin receptors (SSTRs) play an important role in the brain and gastrointestinal (GI) system. SST is produced in various organs and cells, and the inhibitory function of somatostatin-containing cells is involved in a range of physiological functions and pathological modifications. The GI system is the largest endocrine organ for digestion and absorption, SST-endocrine cells and neurons in the GI system are a critical effecter to maintain homeostasisvia SSTRs 1-5 and co-receptors, while SST-SSTRs are involved in chemo-sensory, mucus, and hormone secretion, motility, inflammation response, itch, and painvia the autocrine, paracrine, endocrine, and exoendocrine pathways. It is also a power inhibitor for tumor cell proliferation, severe inflammation, and post-operation complications, and is a first-line anti-cancer drug in clinical practice. This mini review focuses on the current function of producing SST endocrine cells and local neurons SST-SSTRs in the GI system, discusses new development prognostic markers, phosphate-specific antibodies, and molecular imaging emerging in diagnostics and therapy, and summarizes the mechanism of the SST family in basic research and clinical practice. Understanding of endocrines and neuroendocrines in SST-SSTRs in GI will provide an insight into advanced medicine in basic and clinical research.
Keywords: enteric nervous system; gastrointestine (GI); inflammation response; somatostatin; somatostatin receptor.
Copyright © 2021 Shamsi, Chatoo, Xu, Xu and Chen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
- The somatostatin receptor in human pancreatic β-cells.Braun M.Braun M.Vitam Horm. 2014;95:165-93. doi: 10.1016/B978-0-12-800174-5.00007-7.Vitam Horm. 2014.PMID:24559918Review.
- Somatostatin and its receptors in the development of the endocrine pancreas.Ballian N, Brunicardi FC, Wang XP.Ballian N, et al.Pancreas. 2006 Jul;33(1):1-12. doi: 10.1097/01.mpa.0000226894.16817.e8.Pancreas. 2006.PMID:16804406Review.
- Agonist-biased trafficking of somatostatin receptor 2A in enteric neurons.Zhao P, Canals M, Murphy JE, Klingler D, Eriksson EM, Pelayo JC, Hardt M, Bunnett NW, Poole DP.Zhao P, et al.J Biol Chem. 2013 Sep 6;288(36):25689-25700. doi: 10.1074/jbc.M113.496414. Epub 2013 Aug 2.J Biol Chem. 2013.PMID:23913690Free PMC article.
- Colocalization of somatostatin receptor subtypes (SSTR1-5) with somatostatin, NADPH-diaphorase (NADPH-d), and tyrosine hydroxylase in the rat hypothalamus.Kumar U.Kumar U.J Comp Neurol. 2007 Sep 10;504(2):185-205. doi: 10.1002/cne.21444.J Comp Neurol. 2007.PMID:17626271
- Advances in understanding neuronal somatostatin receptors.Selmer I, Schindler M, Allen JP, Humphrey PP, Emson PC.Selmer I, et al.Regul Pept. 2000 Jun 30;90(1-3):1-18. doi: 10.1016/s0167-0115(00)00108-7.Regul Pept. 2000.PMID:10828487Review.
Cited by
- Effect of postoperative utilization of somatostatin on clinical outcome after definitive surgery for duodenal fistula.Tian W, Zhao R, Luo S, Xu X, Zhao G, Yao Z.Tian W, et al.Eur J Med Res. 2023 Feb 3;28(1):63. doi: 10.1186/s40001-023-00988-w.Eur J Med Res. 2023.PMID:36732816Free PMC article.
- Physiological Appetite Regulation and Bariatric Surgery.Ramasamy I.Ramasamy I.J Clin Med. 2024 Feb 27;13(5):1347. doi: 10.3390/jcm13051347.J Clin Med. 2024.PMID:38546831Free PMC article.Review.
- Editorial: Integrative exercise endocrinology.Borer KT, De Sousa MJ, Nindl BC, Stanford KI, Pedersen BK.Borer KT, et al.Front Endocrinol (Lausanne). 2024 Jan 9;14:1350462. doi: 10.3389/fendo.2023.1350462. eCollection 2023.Front Endocrinol (Lausanne). 2024.PMID:38264284Free PMC article.No abstract available.
- Somatostatin-SSTR3-GSK3 modulates human T-cell responses by inhibiting OXPHOS.Zhang B, Feng H, Lin H, Li R.Zhang B, et al.Front Immunol. 2024 Feb 15;15:1322670. doi: 10.3389/fimmu.2024.1322670. eCollection 2024.Front Immunol. 2024.PMID:38426092Free PMC article.
- Emerging pharmacological targets for alcohol use disorder.Brockway DF, Crowley NA.Brockway DF, et al.Alcohol. 2024 Dec;121:103-114. doi: 10.1016/j.alcohol.2024.07.007. Epub 2024 Jul 26.Alcohol. 2024.PMID:39069210Review.
References
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials